How They Won It: Kaye, Munger Ward Off Pay-For-Delay Case

Law360, New York (March 11, 2014, 8:37 PM EDT) -- To shut down a pay-for-delay class action against Pfizer Inc.'s King Pharmaceuticals Inc. and generic-drug maker Mutual Pharmaceutical Co. Inc., attorneys from Kaye Scholer LLP and Munger Tolles & Olson LLP had to figure out how to explain why the U.S. drug distribution system didn't fit the traditional antitrust class certification model. For the defense team, that meant leading with a complex economic story and trusting the judge to come along for the ride.

The suit accused the companies of using a patent settlement to keep...
To view the full article, register now.